Nav: Home

Enzyme lays the foundations for allergic immune response

July 23, 2018

While in search of the causes of allergies and asthma, a chance discovery has yielded new clues: researchers led by Dr Marcus Peters have ascertained that the enzyme guanylate cyclase in cells lays the foundations for the type of immune response. Allergic symptoms are more or less pronounced depending on which immune response gains the upper hand. "This is particularly interesting as there are active pharmaceutical ingredients that stimulate the enzyme or even inhibit it," explains Marcus Peters. The teams from the Experimental Pneumology division at Ruhr-Universität Bochum (RUB) led by Prof Dr Albrecht Bufe and the Pharmacology and Toxicology division led by Prof Dr Doris Koesling report on their discovery in the journal Scientific Reports from 20th July 2018.

Mice without enzyme display fewer symptoms

The enzyme guanylate cyclase is involved in many signalling pathways in cells. It produces the signalling molecule cGMP, which, in turn, has various functions. For instance, it dilates the blood vessels. Active pharmaceutical ingredients that stimulate the enzyme are thus used, among other substances, in patients with pulmonary hypertension.

In studies of with what are known as knock-out mice, which lack an isoform of the enzyme guanylate cyclase, the researchers ascertained that allergic reactions to chicken protein (ovalbumin) among the knock-out mice were less pronounced compared to wild type mice. Further investigations showed that the enzyme plays a role in the allergic immune response.

Various types of immune response

"There are various types of immune response in the body, which differ in terms of the mediator substances released," explains Marcus Peters. What is known as the Th1 response above all serves to defend against infections by viruses and intracellular bacteria, the Th2 response is oriented more towards parasitic infections such as worms. Both types of immune response suppress each other: If the Th1 response is more pronounced, it diminishes the Th2 response and vice versa.

"The Th2 response is the one that triggers the severe symptoms in allergic diseases such as hay fever and asthma," explains Marcus Peters. In the knock-out mice, which lack guanylate cyclase, the Th1 response was more pronounced and thus suppressed the Th2 response. The allergic symptoms were thus weaker than in the wild type mice.

Investigating active pharmaceutical ingredients

"There are active pharmaceutical ingredients that suppress guanylate cyclase," explains Marcus Peters, "although they are not yet in clinical use. It would be very interesting to investigate whether such active pharmaceutical ingredients also have effects on allergies and asthma."
-end-
Funding

The work was financed using research funding from the Faculty of Medicine - Forum Programme (AZ F785-2013).

Original publication

Stefanie Gnipp, Evanthia Mergia, Michelle Puschkarow, Albrecht Bufe, Doris Koesling, Marcus Peters: Nitric oxide dependent signaling via cyclic GMP in dendritic cells regulates migration and T-cell Polarization, in: Scientific Reports, 2018, DOI:10.1038/s41598-018-29287-9, https://www.nature.com/articles/s41598-018-29287-9

Press contact

Prof Dr Albrecht Bufe
Experimental Pneumology
Faculty of Medicine
Ruhr-Universität Bochum
Germany
Phone: +49 234 32 21922
Email: albrecht.bufe@rub.de

Ruhr-University Bochum

Related Asthma Articles:

Breastfeeding and risks of allergies and asthma
In an Acta Paediatrica study, exclusive breastfeeding for the first 3 months was linked with a lower risk of respiratory allergies and asthma when children reached 6 years of age.
Researchers make asthma breakthrough
Researchers from Trinity College Dublin have made a breakthrough that may eventually lead to improved therapeutic options for people living with asthma.
Physics vs. asthma
A research team from the MIPT Center for Molecular Mechanisms of Aging and Age-Related Diseases has collaborated with colleagues from the U.S., Canada, France, and Germany to determine the spatial structure of the CysLT1 receptor.
New knowledge on the development of asthma
Researchers at Karolinska Institutet in Sweden have studied which genes are expressed in overactive immune cells in mice with asthma-like inflammation of the airways.
Eating fish may help prevent asthma
A scientist from James Cook University in Australia says an innovative study has revealed new evidence that eating fish can help prevent asthma.
Academic performance of urban children with asthma worse than peers without asthma
A new study published in Annals of Allergy, Asthma and Immunology shows urban children with poorly controlled asthma, particularly those who are ethnic minorities, also suffer academically.
Asthma Controller Step Down Yardstick -- treatment guidance for when asthma improves
The focus for asthma treatment is often stepping up treatment, but clinicians need to know how to step down therapy when symptoms improve.
Asthma management tools improve asthma control and reduce hospital visits
A set of comprehensive asthma management tools helps decrease asthma-related visits to the emergency department, urgent care or hospital and improves patients' asthma control.
Asthma linked to infertility but not among women taking regular asthma preventers
Women with asthma who only use short-acting asthma relievers take longer to become pregnant than other women, according to research published in the European Respiratory Journal.
What are the best ways to diagnose and manage asthma?
A team of experts from The University of Texas Medical Branch at Galveston examined the current information available from many different sources on diagnosing and managing mild to moderate asthma in adults and summarized them.
More Asthma News and Asthma Current Events

Trending Science News

Current Coronavirus (COVID-19) News

Top Science Podcasts

We have hand picked the top science podcasts of 2020.
Now Playing: TED Radio Hour

Listen Again: Reinvention
Change is hard, but it's also an opportunity to discover and reimagine what you thought you knew. From our economy, to music, to even ourselves–this hour TED speakers explore the power of reinvention. Guests include OK Go lead singer Damian Kulash Jr., former college gymnastics coach Valorie Kondos Field, Stockton Mayor Michael Tubbs, and entrepreneur Nick Hanauer.
Now Playing: Science for the People

#562 Superbug to Bedside
By now we're all good and scared about antibiotic resistance, one of the many things coming to get us all. But there's good news, sort of. News antibiotics are coming out! How do they get tested? What does that kind of a trial look like and how does it happen? Host Bethany Brookeshire talks with Matt McCarthy, author of "Superbugs: The Race to Stop an Epidemic", about the ins and outs of testing a new antibiotic in the hospital.
Now Playing: Radiolab

Dispatch 6: Strange Times
Covid has disrupted the most basic routines of our days and nights. But in the middle of a conversation about how to fight the virus, we find a place impervious to the stalled plans and frenetic demands of the outside world. It's a very different kind of front line, where urgent work means moving slow, and time is marked out in tiny pre-planned steps. Then, on a walk through the woods, we consider how the tempo of our lives affects our minds and discover how the beats of biology shape our bodies. This episode was produced with help from Molly Webster and Tracie Hunte. Support Radiolab today at Radiolab.org/donate.